(ChemotherapyAdvisor) – New guidelines from the United States Preventive Services Task Force (USPSTF) recommend screening for cervical cancer in women 21-65 years of age with cytology (Papanicolaou smear) every 3 years or, for women age 30 to 65 years who want to lengthen the screening interval, a combination of cytology with human papillomavirus (HPV) testing every 5 years.
Radiation therapy (RT) with or without chemotherapy for squamous cell carcinoma (SCC) of the head and neck appears to be less tolerated and less effective in patients who are HIV seropositive compared to observed rates in those without HIV.
Improved screening practices, preventative immunizations, and timely treatment of invasive disease can help reduce the number of deaths due to cervical cancer.
CIPN is a debilitating adverse effect that can lead to reduced doses that hinder treatment effectiveness or early discontinuation of therapy.
CIPN is a debilitating adverse effect that can lead to reduced doses that hinder treatment effectiveness or early discontinuation of therapy.
This article reviews current practices of opioid prescribing in palliative care and suggests some pointers for safe prescribing for these patients.
